ArticleJournal of drug assessment2021

Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis.

Blanca T Pacheco-Soto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.